LDR Medical

About LDR Medical

In 2000, in Troyes, France, seasoned spine executives Christophe Lavigne, Patrick Richard, and Hervé Dinville founded LDR Medical with a singular focus on developing innovative surgical technologies for spinal disorders. They concentrated on creating implants and instruments that offered less invasive procedures and improved patient outcomes compared to existing alternatives. The company’s breakthrough product was the Mobi-C cervical disc. This device gained significant traction after becoming the first and only artificial disc to receive FDA approval in August 2013 for treating both one and two levels of adjacent damaged cervical discs. This approval was a pivotal moment, cementing LDR's position in the fast-growing cervical disc replacement market. Following this success, LDR Holding went public with a NASDAQ IPO in October 2013, raising capital to expand its reach, particularly in the crucial U.S. market. LDR's growth and innovative product line did not go unnoticed. In June 2016, orthopedic giant Zimmer Biomet announced its intention to acquire LDR for approximately $1 billion. The deal, completed in July 2016, was a strategic move for Zimmer Biomet to enhance its own spine division and gain a leading position in the cervical disc replacement segment. For LDR, the acquisition marked the culmination of a 16-year journey from a focused French startup to a key player on the global orthopedic stage, absorbed into a larger entity to scale its technology worldwide.